Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1426]
News [2906]
Articles [125]
Editorials [5]
Conferences [153]
elearning [6]
Drugging “undruggable” transcription factor drivers in cancer
Dr John Bushweller - Unviersity of Virgina, Virginia, USA
Drugging “undruggable” transcription factor drivers in cancer ( Dr John Bushweller - Unviersity of Virgina, Virginia, USA )
28 Apr 2016
Elucidation and pharmacological targeting of tumour checkpoint dependencies
Dr Andrea Califano - Colombia University Medical Centre, New York, USA
Elucidation and pharmacological targeting of tumour checkpoint dependencies ( Dr Andrea Califano - Colombia University Medical Centre, New York, USA )
28 Apr 2016
Identifying myeloid-driven biologies
Dr Brian Ruffell - Moffitt Cancer Center, Tampa, USA
Identifying myeloid-driven biologies ( Dr Brian Ruffell - Moffitt Cancer Center, Tampa, USA )
28 Apr 2016
New technology can potentially overcome CAR T-cell limitations
Dr Philip Low - Purdue University, West Lafayette, USA
New technology can potentially overcome CAR T-cell limitations ( Dr Philip Low - Purdue University, West Lafayette, USA )
27 Apr 2016
Cell of origin role in cancer stem cell and GBM phenotype
Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA
Cell of origin role in cancer stem cell and GBM phenotype ( Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA )
27 Apr 2016
MINDACT breast cancer clinical trial: First results and impact on future trial...
Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium
MINDACT breast cancer clinical trial: First results and impact on future trial design ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
27 Apr 2016
Non-coding mutations driving chronic lymphocytic leukaemia
Dr Xose Puente - University of Oviedo, Oviedo, Spain
Non-coding mutations driving chronic lymphocytic leukaemia ( Dr Xose Puente - University of Oviedo, Oviedo, Spain )
27 Apr 2016
BSH 2016: Expert discussion on front line care in CLL
Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on front line care in CLL ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016
Comparison of three different PD-L1 diagnostic tests shows a high degree of...
Dr Marianne Ratcliffe - AstraZeneca, UK
Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance ( Dr Marianne Ratcliffe - AstraZeneca, UK )
26 Apr 2016
Mutational clonality and intratumour heterogeneity as biomarkers for cancer...
Dr Nicholas McGranahan - Crick Institute, London, UK
Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy ( Dr Nicholas McGranahan - Crick Institute, London, UK )
26 Apr 2016
WIN 2016: Preview of themes
Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona...
WIN 2016: Preview of themes ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
22 Apr 2016
WIN 2016: Preview of Speakers
Dr John Mendelsohn - Chairman of the WIN Consortium
WIN 2016: Preview of Speakers ( Dr John Mendelsohn - Chairman of the WIN Consortium )
22 Apr 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation